This session is part of the SPCC Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project. Following the Task Force - held in 2022 - the third phase of the project will focus on short contributions on the topic by Task Force experts.
Speakers

Discussant
Hope Rugo
Division of Hematology and Oncology at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center, San Francisco, USA

Expert
Hiroji Iwata
Aichi Cancer Center Hospital, Nagoya, Nagoya, Japan
This material is part of Educational
Project:
2022 - Adverse Events Management and Interstitial Lung Disease (ILD) Detection Project